Cargando…
Intranasal Delivery of Bone Marrow Stromal Cells Preconditioned with Fasudil to Treat a Mouse Model of Parkinson’s Disease
OBJECTIVE: Stem cell transplantation is a promising strategy with great potential to treat Parkinson’s disease (PD). Nevertheless, improving the cell delivery route and optimising implanted cells are necessary to increase the therapeutic effect. Herein, we investigated whether intranasal delivery of...
Autores principales: | Tang, Yilin, Han, Linlin, Bai, Xiaochen, Liang, Xiaoniu, Zhao, Jue, Huang, Fang, Wang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986408/ https://www.ncbi.nlm.nih.gov/pubmed/32158210 http://dx.doi.org/10.2147/NDT.S238646 |
Ejemplares similares
-
Association of the serum microRNA-29 family with cognitive impairment in Parkinson's disease
por: Han, Linlin, et al.
Publicado: (2020) -
Fasudil in Combination With Bone Marrow Stromal Cells (BMSCs) Attenuates Alzheimer’s Disease-Related Changes Through the Regulation of the Peripheral Immune System
por: Yu, Jiezhong, et al.
Publicado: (2018) -
Detection of Intranasally Delivered Bone Marrow-Derived Mesenchymal Stromal Cells in the Lesioned Mouse Brain: A Cautionary Report
por: Chartoff, Elena H., et al.
Publicado: (2011) -
Delayed and repeated intranasal delivery of bone marrow stromal cells increases regeneration and functional recovery after ischemic stroke in mice
por: Chau, Monica J., et al.
Publicado: (2018) -
Preconditioning of Rat Bone Marrow-Derived Mesenchymal Stromal Cells with Toll-Like Receptor Agonists
por: Evaristo-Mendonça, Fabiana, et al.
Publicado: (2019)